We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Benitec licensee’s Oncolys deal to commercialise Hep C drug

News   Mar 13, 2008

 
Benitec licensee’s Oncolys deal to commercialise Hep C drug
 
 
 

RELATED ARTICLES

New Genetic Cause of Liver Fat Uncovered

News

New research has uncovered genetic variations that may contribute to the development of non-alcoholic fatty liver disease (NAFLD), the leading cause of liver disease.

READ MORE

Deer Antler Proliferation Genes Profiled In Vitro

News

Deciphering the genetics behind antler regeneration, rapid bone growth and mineralization may aid the development of effective therapies for bone diseases and fractures.

READ MORE

Detecting Plaque Formation by Tracking Vascular Muscle Cell Activity

News

Catching cells in the act of switching from 'pumping' to 'repair' mode with the use of single-cell RNA sequencing should raise alarms, researchers say.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE